223 related articles for article (PubMed ID: 32144047)
1. A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.
Martin JW; Jefferson FA; Huang M; Sung JM; Chang J; Piranviseh K; Ziogas A; Anton-Culver H; Youssef RF
Clin Genitourin Cancer; 2020 Jun; 18(3):e330-e336. PubMed ID: 32144047
[TBL] [Abstract][Full Text] [Related]
2. Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.
Martin JW; Vernez SL; Lotan Y; Abdelhalim A; Dutta R; Shokeir A; Abol-Enein H; Mosbah A; Ghoneim M; Youssef RF
World J Urol; 2018 Nov; 36(11):1835-1843. PubMed ID: 29761225
[TBL] [Abstract][Full Text] [Related]
3. Lymphovascular invasion is associated with oncologic outcomes following radical cystectomy for squamous cell carcinoma of the urinary bladder.
Spradling K; Lotan Y; Shokeir A; Abol-Enein H; Mosbah A; Morgan JB; Ghoneim M; Youssef RF
Urol Oncol; 2016 Sep; 34(9):417.e1-8. PubMed ID: 27157247
[TBL] [Abstract][Full Text] [Related]
4. Sociodemographic and survival disparities for histologic variants of bladder cancer.
Jue JS; Koru-Sengul T; Moore KJ; Miao F; Alameddine M; Nahar B; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972
[TBL] [Abstract][Full Text] [Related]
5. The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
Matulay JT; Woldu SL; Lim A; Narayan VM; Li G; Kamat AM; Anderson CB
Urol Oncol; 2019 Jun; 37(6):353.e17-353.e24. PubMed ID: 30704959
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of non-urothelial carcinoma of bladder: analysis of nationwide hospital-based cancer registry data in Japan.
Nagumo Y; Kawai K; Kojima T; Shiga M; Kojo K; Tanaka K; Kandori S; Kimura T; Kawahara T; Okuyama A; Higashi T; Nishiyama H
Jpn J Clin Oncol; 2020 Sep; 50(9):1068-1075. PubMed ID: 32469066
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014.
Andreassen BK; Aagnes B; Gislefoss R; Andreassen M; Wahlqvist R
BMC Cancer; 2016 Oct; 16(1):799. PubMed ID: 27737647
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study.
Nuhn P; Novara G; Seitz C; Gupta A; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Tritschler S; Martínez-Salamanca JI; Ficarra V; Karakiewicz PI; Mazzoleni G; Shariat SF; Bastian PJ
World J Urol; 2015 Jul; 33(7):1005-13. PubMed ID: 25048439
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of squamous histology in bladder cancer: a population-based study.
Izard JP; Siemens DR; Mackillop WJ; Wei X; Leveridge MJ; Berman DM; Peng Y; Booth CM
Urol Oncol; 2015 Oct; 33(10):425.e7-13. PubMed ID: 26199176
[TBL] [Abstract][Full Text] [Related]
10. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
[TBL] [Abstract][Full Text] [Related]
11. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
[TBL] [Abstract][Full Text] [Related]
12. Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.
Sung JM; Martin JW; Jefferson FA; Sidhom DA; Piranviseh K; Huang M; Nguyen N; Chang J; Ziogas A; Anton-Culver H; Youssef RF
Clin Genitourin Cancer; 2019 Oct; 17(5):e995-e1002. PubMed ID: 31239240
[TBL] [Abstract][Full Text] [Related]
13. Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base.
Cohen AJ; Packiam V; Nottingham C; Steinberg G; Smith ND; Patel S
Urol Oncol; 2017 Jan; 35(1):34.e1-34.e8. PubMed ID: 27592529
[TBL] [Abstract][Full Text] [Related]
14. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
Marks P; Gild P; Soave A; Janisch F; Minner S; Engel O; Vetterlein MW; Shariat SF; Sauter G; Dahlem R; Fisch M; Rink M
Surg Oncol; 2019 Mar; 28():208-213. PubMed ID: 30851902
[TBL] [Abstract][Full Text] [Related]
15. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
[TBL] [Abstract][Full Text] [Related]
16. Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Jun; 15(3):e463-e468. PubMed ID: 27876505
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy.
Krasnow RE; Drumm M; Roberts HJ; Niemierko A; Wu CL; Wu S; Zhang J; Heney NM; Wszolek MF; Blute ML; Feldman AS; Lee RJ; Zietman AL; Shipley WU; Efstathiou JA
Eur Urol; 2017 Jul; 72(1):54-60. PubMed ID: 28040351
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic utility of PD-L1 in patients with squamous cell carcinoma of the bladder.
Owyong M; Lotan Y; Kapur P; Panwar V; McKenzie T; Lee TK; Zi X; Martin JW; Mosbah A; Abol-Enein H; Ghoneim M; Youssef RF
Urol Oncol; 2019 Jul; 37(7):478-484. PubMed ID: 30910351
[TBL] [Abstract][Full Text] [Related]
19. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma.
Abel S; Hasan S; White R; Schumacher L; Finley G; Colonias A; Wegner RE
Lung Cancer; 2019 Feb; 128():127-133. PubMed ID: 30642444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
